Sanofi opens cell culture plant at Industriepark Höchst
Pharmaceutical company strengthens integrated research and development platform
Sanofi commissioned its new cell culture plant at Industriepark Höchst in June 2011. The diversifyed healthcare company invested around EUR 30 million to build the plant, which will produce monoclonal antibodies using biotechnological processes. Monoclonal antibodies are highly specialized protein molecules that inhibit disease or marshal the body’s natural defenses against illness. These therapeutic antibodies can be used to help heal wounds and treat various forms of cancer, diabetes, autoimmune diseases and infections. Around 80 employees at the cell culture plant will produce the antibodies for preclinical and clinical trials. The cell culture plant – which more than doubles the cell culture production capacity at the site – has come online at the right time for Sanofi : it is focusing more and more on targeted biopharmaceutical therapies, a fast-growing worldwide market.
Reinforced market position
“I am thrilled that we have successfully expanded this cutting-edge technology within the group in Frankfurt,” explained Martin Siewert, General Manager of Sanofi -Aventis Deutschland GmbH. “The new cell culture plant adds a valuable component to our integrated research and development platform at the park and reinforces Sanofi ’s overall position in the biotech market.” Industriepark Höchst is the only Sanofi
site worldwide that has activities in every stage of drug discovery and development.
Categories
Related parks
Investments
Countries
Companies
Latest news
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Sartorius will acquire all outstanding shares of Albumedix Ltd. for approximately £415 million. UK-based Albumedix Ltd. is a leader in the field of recombinant albumin-based solutions and a highly ...
INEOS at Grangemouth backs bid for Forth Green Freeport
In backing the bid for the Forth Green Freeport, INEOS recognises the important and significant role this region has to play in achieving the Scottish and UK Governments’ net zero targets.
The Mitsubishi Chemical Group to Boost Production of SoarnoL™ EVOH Resin at Hull, UK
SoarnoL™ is a high gas-barrier resin used to produce packaging materials that help prolong the flavor and quality of foods, resulting in reduced food waste.
BASF transforms market towards certified, sustainably sourced coconut oil in Cassina Rizzardi, Italy
BASF first chemical company offering Rainforest Alliance Certified personal care ingredients based on coconut oil. Production site in Cassina Rizzardi, Italy, certified according to Rainforest Alli...